|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 47/18 | (2006.01) |
| A61K 38/21 | (2006.01) | ||
| A61K 9/08 | (2006.01) |
| (11) | Number of the document | 0948358 |
| (13) | Kind of document | T |
| (96) | European patent application number | 97952621.7 |
| Date of filing the European patent application | 1997-12-23 | |
| (97) | Date of publication of the European application | 1999-10-13 |
| (45) | Date of publication and mention of the grant of the patent | 2004-07-14 |
| (46) | Date of publication of the claims translation | 2004-11-25 |
| (86) | Number | PCT/US1997/023817 |
| Date | 1997-12-23 |
| (87) | Number | WO 1998/028007 |
| Date | 1998-07-02 |
| (30) | Number | Date | Country code |
| 34353 P | 1996-12-24 | US |
| (72) |
DIBIASI, Mary, D., US
STAPLES, Mark, US
CHUNG, Wen-Li, US
SCHARIN, Eric, US
|
| (73) |
Biogen MA Inc.,
250 Binney St., Cambridge MA 02142,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Stabilios skystosios interferono kompozicijos |
| STABLE LIQUID INTERFERON FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2016-12-01 | 20 | 347.00 EUR |